Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
11
|
| pubmed:dateCreated |
1981-3-24
|
| pubmed:abstractText |
6-Substituted 5-hydroxymethylimidazo[2.1-b]thiazoles and 2,3-dihydro-5-hydroxymethylimidazo[2,1-b]thiazoles (VII - XII) were prepared by reducing the corresponding aldehydes (I - VI) with NaBH4. Among the acetic (VII a - XII a), methylcarbamic (VII b - XII b) and ethylcarbamic esters (VII c - XII c), compound (VII a) was active in a preliminary P388 leukemia test.
|
| pubmed:language |
ita
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Nov
|
| pubmed:issn |
0430-0920
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
35
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
896-901
|
| pubmed:dateRevised |
2009-6-5
|
| pubmed:meshHeading | |
| pubmed:year |
1980
|
| pubmed:articleTitle |
[Compounds with potential antitumor activity. VI. Esters of 6-substituted 5-hydroxymethylimidazo(2,1-b)thiazoles].
|
| pubmed:publicationType |
Journal Article,
English Abstract
|